Sandoz Buys Maker Of Dermatology Drugs | Chemical & Engineering News
Volume 90 Issue 19 | p. 17 | Concentrates
Issue Date: May 7, 2012

Sandoz Buys Maker Of Dermatology Drugs

Department: Business
Keywords: acquisitions, generics, dermatology

Novartis’ Sandoz unit will acquire Fougera Pharmaceuticals, a specialty dermatology generics company, for $1.5 billion in cash. Fougera is the former dermatology division of Nycomed, the rest of which was acquired last year by Takeda Pharmaceutical. Based in Melville, N.Y., Fougera had 2011 sales of $429 million. Sandoz says the purchase will make it the world’s number one generic dermatology medicines company with annual sales of about $620 million, primarily in the U.S.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment